Skip to main content
SOPHiA GENETICS logo

SOPHiA GENETICS — Investor Relations & Filings

Ticker · SOPH ISIN · CH1125843347 LEI · 506700H1GPU9GGM8W895 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 295 across all filing types
Latest filing 2026-05-19 Foreign Filer Report
Country CH Switzerland
Listing US SOPH

About SOPHiA GENETICS

https://www.sophiagenetics.com

SOPHiA GENETICS is an AI-powered healthcare technology company focused on advancing data-driven medicine. Its core offering is the SOPHiA DDM™ platform, a cloud-based system that utilizes artificial intelligence to analyze complex genomic and multimodal health data. The platform provides actionable insights to healthcare professionals, supporting diagnosis and treatment primarily in the fields of oncology and rare or inherited diseases. By connecting a global network of healthcare institutions, SOPHiA GENETICS creates a collective intelligence that aims to improve analytical accuracy and democratize access to precision medicine, ultimately enhancing patient outcomes worldwide.

Recent filings

Filing Released Lang Actions
6-K
Foreign Filer Report
2026-05-19 English
6-K - SOPHiA GENETICS SA (0001840706) (Filer)
Foreign Filer Report
2026-05-08 English
6-K - SOPHiA GENETICS SA (0001840706) (Filer)
Foreign Filer Report
2026-05-05 English
4 - SOPHiA GENETICS SA (0001840706) (Issuer)
Director's Dealing
2026-03-20 English
4 - SOPHiA GENETICS SA (0001840706) (Issuer)
Director's Dealing
2026-03-20 English
4 - SOPHiA GENETICS SA (0001840706) (Issuer)
Director's Dealing
2026-03-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.